CTN Translation & Implementation SIG

The SIG aims to enhance the CTN platform by examining implementation factors in clinical trials, in order to increase understanding of the likelihood for successful translation. The SIG likewise aims to improve the equitable sustainment of CTN-studied interventions that have been proven to be effective.

The SIG meets bimonthly via Zoom at Noon Eastern on the 3rd Tuesday of the month, and the workgroups meet during the months in between.

Upcoming webinars: TBA

Contact Helene Chokron Garneau at hchokgar@stanford.edu if you would like to attend!

T&I SIG Webinars and Presentations

To join or to be informed about the CTN T&I SIG or the workgroups, contact:

Mark McGovern
mpmcg@stanford.edu
Stanford University School of Medicine

Helene Chokron Garneau
Helene.chokrongarneau@stanford.edu
Stanford University School of Medicine

SIG Workgroups

Implementation Outcomes

Jennifer McNeely
Jennifer.Mcneely@nyulangone.org
New York University School of Medicine

Joseph Glass
Joseph.E.Glass@kp.org
Kaiser Permanente Washington Health Research Institute

Health Equity

Kelly Aschbrenner
Kelly.A.Aschbrenner@dartmouth.edu
Geisel School of Medicine at Dartmouth College

Hoa Vo
Hoa.Vo@UTSouthwestern.edu

University of Texas Southwestern

Implementation Strategies

Jennifer Becan
j.becan@tcu.edu
Texas Christian University

Bryan Hartzler
hartzb@uw.edu
University of Washington

Early Career Investigators

Miranda Greiner
Miranda.Greiner@nyspi.columbia.edu
Columbia University

Oladunni Oluwoye
oladunni.oluwoye@wsu.edu
Washington State University